JPS59116226A - Hypotensive agent made from juice of gramineous plant - Google Patents
Hypotensive agent made from juice of gramineous plantInfo
- Publication number
- JPS59116226A JPS59116226A JP58217830A JP21783083A JPS59116226A JP S59116226 A JPS59116226 A JP S59116226A JP 58217830 A JP58217830 A JP 58217830A JP 21783083 A JP21783083 A JP 21783083A JP S59116226 A JPS59116226 A JP S59116226A
- Authority
- JP
- Japan
- Prior art keywords
- component
- juice
- green
- aqueous solution
- green juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
本発明はイネ科植物の緑葉の青汁成分に含有する血圧降
下作用を示す成分を有効成分として含有することを栃徴
とするイネ科稙物青汁源血圧降下剤に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides a green juice source antihypertensive agent from the grass family, which is characterized by containing, as an active ingredient, a component exhibiting a blood pressure lowering effect, which is contained in the green juice component of the green leaves of a grass family plant. Regarding.
更に詳しくは、本発明は、イネ科植物の緑葉の青汁成分
から得られる水可溶部の水溶液から、該水溶液容量に基
いて60〜80容量%の極性溶媒の添加により形成され
る不溶性固形分及び/又は該水溶液を70°〜100℃
に加熱することにより形成される不溶性固形分を除去し
た成分、或は該不溶性固形分を除去しだ液相を更にゲル
濾過処理した成分、を有効成分として含有することを特
徴とするイネ科植物青汁源血圧降下剤に関する。More specifically, the present invention provides an insoluble solid that is formed by adding 60 to 80% by volume of a polar solvent based on the volume of the aqueous solution from an aqueous solution of a water-soluble portion obtained from a green juice component of green leaves of a grass family plant. minutes and/or the aqueous solution at 70° to 100°C.
A gramineous plant characterized by containing as an active ingredient a component obtained by removing an insoluble solid content formed by heating to , or a component obtained by further gel filtration of a liquid phase after removing the insoluble solid content. Regarding green juice source blood pressure lowering agent.
イネ科植物たとえば麦類の成熟期前の緑葉の青汁成分が
、食品、飲料、嗜好品、保健薬、化粧品、医薬品を包含
する広い食品、医薬用用途に有用な多様且つ豊富な有用
成分を含有することは知られており、その上うな青汁成
分の乾燥粉末を製造するのに、麦類の成ソI(期1ii
jの機械的破砕物からJll−’、に:固It?分を分
離除去して4jYられる青!1”の1+I−(G〜9に
中和したちのを、噴霧乾燥又は凍結く・a燥することを
1、テ徴とする方法が知られている(1」本国性3′1
第6・l !; 、’、478号;特公昭4G−985
48号;メ1J応米国特3′[第、’(、787+ 5
91号)。発明者はrjられなイネ科植物の若葉のエキ
ス末即ち青汁末を麦緑素と名(=1けた。そして、該青
汁成分の食品用や保健薬もしくは医薬としての作用につ
いての研究を進めた。The green juice component of the green leaves of gramineous plants, such as barley, contains a wide variety of useful ingredients that are useful for a wide range of food and pharmaceutical applications, including foods, beverages, luxury goods, health drugs, cosmetics, and pharmaceuticals. Moreover, in order to produce the dry powder of eel green juice ingredients, barley Seiso I (stage 1ii) is used.
From the mechanical crushing of j to Jll-', to: solid It? Blue that can be separated and removed and 4jY! A known method is to spray-dry or freeze/dry a mixture that has been neutralized to 1 + I- (G ~ 9) as a sign of 1.
6th l! , ', No. 478; Special Publication Show 4G-985
No. 48; Me 1J International Special Edition 3' [No. 48; 787 + 5
No. 91). The inventor named the powder of the extract of young leaves of the gramineous plant, ie, the powder of green juice, as barley green (=1 digit), and conducted research on the action of the green juice component for food use, as a health drug, or as a medicine. I proceeded.
本発明者は青汁中に、特にイネ科植物の青汁及びその乾
燥粉末か、人間の血圧の異常を正常化するように調節し
、高血圧症の防止に著しく有効であることを見出し、イ
ネ科植物の青汁の服用の効用の一つと考え、イネ科植物
の青汁中に高血圧症を防ぐ作用のあるものがあることを
示唆して発明者の著書〔驚異の健康シ原麦緑素、祥伝社
発行1976年4月5日。緑の血液、青汁の効用、旧本
青汁−梓及会発行。〕をはじめ、各種の刊行物で公はに
しできた。The present inventor found that green juice, especially green juice of grass family plants and its dry powder, is extremely effective in regulating blood pressure abnormalities in humans and preventing hypertension. This is considered to be one of the benefits of taking green juice from grasses, and the inventor's book ``Amazing Healthy Barley Green'' suggests that there is something in the green juice of grasses that has the effect of preventing hypertension. , published by Shodensha on April 5, 1976. Green Blood, The Benefits of Green Juice, Old Book of Green Juice - Published by Azusa Okikai. ] and various other publications.
発明名は更iご研究を進め青汁そのちのか血j1′、降
下作用を有することをつきとめ、該作用を不孝−成分を
工業的に有利な方法で製造するノj法を開発すべく研究
を1jっできた。その結果、イネ科植物の緑葉(茎及び
葉を総称する)の青汁およびそのエキス末即ち麦緑素そ
のものを被試験動物に経口投jyしても明らかに血圧降
下作用を示す二と即ち青汁およりそのエキス末自体が血
圧降下剤として有用て゛あることを確認するに至った。The name of the invention was further researched and it was discovered that green juice had a blood-depressing effect, and research was carried out to develop a method for producing this effect by an industrially advantageous method. I finished 1j. As a result, we found that even when the green juice of green leaves (stem and leaves are collectively called) of grasses and its extract powder, that is, barley green itself, was orally administered to test animals, it clearly showed a blood pressure lowering effect. We have now confirmed that the extract powder itself is useful as a hypotensive agent.
更に青汁およびそのエキス末より血圧降下有効成分をよ
り濃J?、なより純度の高い状態のものとして、」二業
的に有利に取翁1する方法を発見した。即ちイネ科植物
の緑葉(茎及び葉を総称する)の機械的破砕物から粗大
固形分を分離除去して得られる青汁成分から、例えば遠
心分離や濾過法、凝集沈降法等の手段により青汁中の微
細な懸濁固形分を除去して得られるような水可溶性部、
域は」二記租犬固形分を除去した青汁成分を例えば噴霧
乾燥や凍結乾燥等で粉末化した青汁エキス末を水性媒体
に再溶解して、微細な懸濁固形分を除去して得られる水
可溶性部に降血圧作用か′あること、即ち降血圧作用を
示す成′Irが該水1f溶性部に存在することを見い出
した。Furthermore, it contains more concentrated blood pressure lowering active ingredients than green juice and its extract powder. We have discovered a way to obtain this product in a more highly pure state, which is advantageous for both businesses. That is, from the green juice component obtained by separating and removing coarse solids from the mechanically crushed green leaves (generally referred to as stems and leaves) of grass plants, green juice is extracted by means such as centrifugation, filtration, and coagulation sedimentation. water-soluble part, such as that obtained by removing fine suspended solids in juice;
The green juice component from which the solid content has been removed is pulverized by spray drying, freeze drying, etc., and the green juice extract powder is redissolved in an aqueous medium to remove the fine suspended solid content. It has been found that the resulting water-soluble portion has a blood pressure lowering effect, that is, Ir, which exhibits a blood pressure lowering effect, is present in the water-soluble portion.
更にこの水rif溶性部の水溶液に、該水溶液容量に基
いて約60・〜約80容量%好ましくは約70〜約80
容量%の極性溶媒たとえば低級アルコールを添加するこ
とにより形成される固形分及び/又は詠水溶液を約70
”〜約100 ”Cに加熱した際に形成される固形分を
除去するという工業的に操作容易な手段で、青汁成分中
の血圧降下成分を、該水可溶部中に共存し得る不都合な
他の扶雑諸成分から選択的に分離できることを発見した
。Furthermore, about 60% to about 80% by volume, preferably about 70% to about 80% by volume, is added to the aqueous solution of the water rif-soluble portion, based on the volume of the aqueous solution.
The solid content and/or the aqueous solution formed by adding % by volume of a polar solvent such as a lower alcohol is approximately 70% by volume.
The industrially easy-to-operate means of removing the solid content formed when heated to about 100°C can eliminate the disadvantage that the blood pressure-lowering components in the green juice component may coexist in the water-soluble portion. It was discovered that it can be selectively separated from other complex components.
更に、例えば、」二記搾汁から4■犬固形分を除した青
汁をそのまま、或は上記青汁成分粉末の再溶解物をその
まま、約60°C以上の温度に加熱して、形成される固
形分を除去することによって、約6(1”C以上の熱履
歴を実質的に受けさせた青汁成分がら(j7られた水可
溶部を用いたり、或は又、水可溶部に上記濃度条件を逸
脱した条件で極性溶媒を添加したり及び/又は上記加熱
条件を逸脱した条件で加熱したりして、形Iti、すれ
る固形分を除去した場合には、得られる製品の血圧降下
作用は低下することかわがった。従って、青汁或は青汁
成分末より上記水可溶性部を収得する際に青汁或はi″
f汁成分末の水再溶解液を約60°以上の温度に実質的
な時間加熱し、約60°以」二の熱履歴を実質的に受け
さすことは好ましくないことがわがった。Furthermore, for example, the green juice obtained by removing the solid content from the squeezed juice described in Section 2, or the redissolved product of the green juice component powder as described above, may be heated to a temperature of about 60° C. or higher to form it. By removing the solid content, it is possible to use the water-soluble part that has been subjected to a heat history of about 6 (1"C or more), or alternatively, If a polar solvent is added to the part under conditions that deviate from the above concentration conditions and/or the solid content is removed by heating under conditions deviating from the above heating conditions, the resulting product It was found that the blood pressure-lowering effect of green juice or
It has been found that it is not preferable to heat the water redissolved liquid of the f-juice component powder to a temperature of about 60° or higher for a substantial period of time and to subject it to a substantial thermal history of about 60° or higher.
その1M1由は明らかではないが、原料のイネ科植物緑
葉の青汁成分は天然源の複雑な複合成分で゛あって、例
えは、アミノ酸類、蛋白質類、カム質類、多糖類、配糖
体類、葉緑素、カロチン等の色素類、醇素頬、ミネラル
類、サポニン等々の極めて多種多様な種類及び性質及び
゛状態の成分が、互いに影響し合ったバランスを保って
、化学的及び物理的に+q*、aしたり結合したり脱離
した1)シてコロイド状態を伴って共存する系である。Although the reason for 1M1 is not clear, the green juice component of the green leaves of the grass family, which is the raw material, is a complex compound of natural sources, such as amino acids, proteins, camouflages, polysaccharides, and saccharides. A very wide variety of types, properties, and states of ingredients, such as pigments such as macrophytes, chlorophyll, and carotene, minerals, and saponins, interact with each other to maintain a chemical and physical balance. It is a system in which +q*, a, bonding, and detachment (1) coexist in a colloidal state.
そして、この複雑な系中に存在する血圧降下作用を示す
成分系の実態及υ共77状態は、全く不明である。従っ
て、1−記熱履歴条1′1、極性溶媒濃度条件及び加熱
条件を逸脱すると、とのような作用(幾序によって血圧
降下作用を示す成分系部分か、どのようにして失われる
かは全く不明であるが、上記部条件が適用される時期の
変更によって、上記複雑な共存系中に存在する多様な成
分間に、互いに影響し合う多くの変化が生じ、例えば、
凝集する固形分への有用成分の吸着や包接現象、有用成
分の不都合な変性や分解もしくは会合現象、インヒビタ
ー成分もしくは非有用成分の不都合な遊離や有用成分と
の結合現象、等々の現象が互いに影響し合ってイノ1起
するために生ずるものと推測している。例えば、後に比
較のために示す比較例Aには、植物の水性抽出エキスを
採取するのに慣用の加熱濃縮手段を用い、大麦の若葉の
搾汁から粗大固形物を除去して得た青汁から水可溶部を
採取することなく、そのまま約90°Cに20分間加熱
し形成される固形分を除去して水可溶部を用いる外は製
造例1と同様に処理して得た成分は、血圧降下作用にお
いてすっと劣ることがt’l+明した。Furthermore, the actual state of the component system that exhibits the blood pressure lowering effect that exists in this complex system and the state of υ77 are completely unknown. Therefore, if the polar solvent concentration conditions and heating conditions are deviated from 1-thermal history article 1'1, the effect (the part of the component system that exhibits a blood pressure lowering effect depending on the order), and how it is lost is unknown. Although it is completely unclear, changes in the timing when the above conditions are applied will result in many changes that influence each other among the various components present in the above complex coexistence system, such as:
Phenomena such as adsorption or inclusion of useful components in coagulating solids, unfavorable denaturation, decomposition, or association of useful components, undesirable release of inhibitor components or non-useful components, or binding phenomena with useful components, etc. It is speculated that this is caused by mutual influence and innovation. For example, in Comparative Example A, which will be shown later for comparison, a green juice obtained by removing coarse solids from the squeezed juice of young barley leaves using a heating concentration method conventionally used to collect aqueous extracts of plants. A component obtained by processing in the same manner as in Production Example 1, except that the water-soluble part was heated as it was at about 90 ° C for 20 minutes without collecting the water-soluble part, and the solid content formed was removed and the water-soluble part was used. t'l+ was found to be significantly inferior in blood pressure lowering effect.
従って、本発明の目的はイネ科植物の緑葉の天然青汁成
分から1υ−られた該成分中に含有される血圧降下作用
を示す成分を、有効成分として含有する天然源血圧降下
剤を提供するにある。Therefore, the object of the present invention is to provide a naturally sourced hypotensive agent containing as an active ingredient a component that exhibits a hypotensive effect contained in the natural green juice component of the green leaves of a grass family plant. It is in.
本発明の」二記目的及び更に多くの池の目的ならひ゛に
利点は、以下の記載から一層明らかとなるであろう。The advantages of the above objects and other objects of the present invention will become more apparent from the following description.
本発明で利用する有効成分は、イネ科植物の緑葉の青汁
成分から得られる、好ましくは約6+1’以上の熱履歴
を受けていない青汁成分中の水可溶部の水溶液から、該
水溶液容量に基いて約60〜約80容量%の極性溶媒に
より形成される固形分及び/又は該水溶液の約70°〜
約100 ”Cの加熱により形成される固形分を除去す
ることにより、該青汁中の血圧降下成分として採取する
ことかできる。The active ingredient used in the present invention is obtained from a green juice component of green leaves of a grass family plant, preferably from an aqueous solution of the water-soluble portion of the green juice component that has not undergone a thermal history of about 6+1' or more. Solids formed by about 60% to about 80% by volume of polar solvent and/or about 70° to about 70% of the aqueous solution
By removing the solid content formed by heating at about 100''C, it can be collected as a blood pressure lowering component in the green juice.
上記イネ科植物の例としては、イネ、小麦、大麦、ライ
麦、エン麦、ハトムギ、イタリアンダイクラス、トウモ
ロコシ、サトウキビ、ソルカ゛ム、粒などを例示するこ
とがでとる。これらの中でも麦類の利用が好ましい。Examples of the above-mentioned grasses include rice, wheat, barley, rye, oats, adlay, Italian dicrase, corn, sugarcane, solium, and grains. Among these, it is preferable to use wheat.
本発明で利用する有効成分を得るには、」二記例示の如
きイネ科植物の緑葉(葉、茎を包含する呼称)の青汁成
分中の水可溶部を利用する。該緑葉として麦類を利用す
る場合には最大分ケッ期もしくはその前後の緑葉の利用
が好ましい。この際、該水可溶部を採取する以前に、該
青汁成分に約60°C以上の熱履歴を与えないことが好
ましい。但し、ここで約60℃以上の熱履歴を与えない
と称するのは、実質的な熱履歴が生ずる時間、そのよう
な温度にさらさないことを意味する。従って、瞬間加熱
殺菌、加熱噴霧乾燥の如き、該青汁成分に約60℃以上
の実質的な熱履歴を与えない捏作に、該青汁成分を賦す
ることを除外するものではない。例えば、青汁成分の煮
沸加熱濃縮の如き、実質的な熱履歴の賦与を除外する意
味である。In order to obtain the active ingredient used in the present invention, the water-soluble portion in the green juice component of the green leaves (a term that includes leaves and stems) of grass plants such as those illustrated in Section 2 is utilized. When using wheat as the green leaves, it is preferable to use green leaves at or around the maximum ripening stage. At this time, it is preferable not to subject the green juice component to a thermal history of about 60° C. or higher before collecting the water-soluble portion. However, here, the term "not imparting a thermal history of about 60° C. or higher" means that the material is not exposed to such a temperature for a period of time during which a substantial thermal history occurs. Therefore, it is not excluded that the green juice component is added to fabrications that do not give the green juice component a substantial thermal history of about 60° C. or higher, such as instant heat sterilization or heat spray drying. For example, it is meant to exclude imparting a substantial thermal history, such as boiling and heat concentration of green juice components.
例えば、イネ科植物の緑葉の機械的搾汁たとえば、磨砕
磯、搾汁機などの如き手段で破細したイネ科植物緑葉か
ら、粗大固形分及び微細固形分を包含して固形分を除去
した搾汁水相を、−に記青汁成分中の水可溶部として利
用することができる。For example, by mechanically squeezing green leaves of grasses, for example, solids including coarse solids and fine solids are removed from shredded green leaves of grasses using a crushing stone, a juicer, etc. The squeezed aqueous phase can be used as the water-soluble portion in the green juice component described in -.
固形分の除去は1段で行ってもよいし多段で行うことも
できる。例えば、まず粗大固形分を炉別除去したのち、
更に適当な1戸紙、炉布、その他のが材を用いて咬過し
、或は遠心分離により微細固形分を除去した水相を利用
することができる。或は例えば上述の如き粗大固形分を
除去した搾汁即ち青汁、もしくは粗大固形分及び微細固
形分を除去した搾汁を噴霧乾燥、凍結乾燥の如き該水可
溶部に好ましくは約60℃以上の熱履歴を実質的に与え
ない条件下で乾燥して得られる青汁成分乾燥物もしくは
その水可溶部の乾燥物を水に再溶解し、さらに必要に応
し固形分を除去して得られた水相を利用することかで′
きる。本発明で利用する」−記例示の如き水相は、通常
、淡黄褐色乃至黄褐色の水溶Mて゛ある。The solid content may be removed in one stage or in multiple stages. For example, after first removing coarse solids by furnace,
Furthermore, it is possible to use an aqueous phase from which fine solids have been removed by chewing with suitable paper, oven cloth, or other materials, or by centrifugation. Alternatively, for example, the above-mentioned squeezed juice from which coarse solids have been removed, that is, green juice, or the squeezed juice from which coarse and fine solids have been removed, may be spray-dried or freeze-dried to the water-soluble portion, preferably at about 60°C. The dried green juice component obtained by drying under conditions that do not substantially give the above thermal history or the dried product of its water-soluble portion is redissolved in water, and if necessary, the solid content is removed. By using the obtained aqueous phase,
Wear. The aqueous phase used in the present invention as exemplified above is usually a light yellowish brown to yellowish brown aqueous phase.
本発明で利用する有効成分を採取するには、たとえは」
−述のようにして得ることのできるイネ科411′i物
の緑葉の青汁成分からイυられる、好ましくは約6+1
’C以上の熱履歴を受けていなし・青汁成分中の水可溶
部の水溶液から、該水溶液容量に基いて約60〜約8(
)容量%、好ましくは約7()〜約80容量%の極性1
8幌5を添加した際に形成される固形分及び詠水溶液を
約マ()°−4,!31 (l O’C1好ましくは約
80°〜約100’Cに加熱した際に形成される固形分
のいずれか−・方もしくは両者、好ましくは両者を除去
する。両者を除去する場合には、どちらの固形分を先に
除去しても差支えないか、加熱固形分を除去したのち、
極性溶媒による固形分を除去するのか操作上有利である
。To collect the active ingredients used in the present invention, the following example is used.
- obtained from the green juice component of the green leaves of Poaceae 411′i which can be obtained as described above, preferably about 6+1
From an aqueous solution of the water-soluble portion of the green juice component that has not undergone a thermal history of 'C or higher, approximately 60 to approximately 8 (
) volume %, preferably from about 7 ( ) to about 80 volume % polarity 1
The solid content and the water solution formed when adding 8 poro 5 are approximately Ma()°-4,! 31 (l O'C1 Preferably, either or both of the solids formed when heated to about 80° to about 100'C, preferably both, are removed. When both are removed, Which solid content can be removed first? After removing the heated solid content,
It is operationally advantageous to remove solids using polar solvents.
上記極性溶媒としては、メタノール、エタ/−ル、プロ
パ/−ルの如きアルコール類、アセトンなどを例示する
ことができる。又、」二記極性溶媒による固形分の除去
及び/又は加熱固形分の除去繰作は複数回行うことかで
きる。固形分の除去は、任意の同一液分離手段で・行う
ことかでき、例えば、2濾過、遠心分離なとの手段を例
示することかできる。Examples of the polar solvent include alcohols such as methanol, ethanol, propyl, and acetone. Further, the removal of the solid content using the polar solvent and/or the removal of the solid content by heating may be performed multiple times. Removal of the solid content can be carried out using any liquid separation means, such as 2-filtration and centrifugation.
又、上記極性溶媒による固形分の形成操作は室温で行わ
れるか望むならは、当詠極性溶媒水溶液の沸点以下の温
度条件を採用することもできる1゜」二連のようにして
得られた液相は、例えば減圧乾燥、uni ′Is乾燥
、凍結乾燥などの一12段で液分を除去し、褐色乃至黄
褐色の粉末状として144(+中の血圧降下成分を固体
としてイUることか゛できる。In addition, the solid content formation operation using the polar solvent may be carried out at room temperature, or if desired, a temperature condition below the boiling point of the polar solvent aqueous solution may be adopted. The liquid phase is obtained by removing the liquid component in 12 steps such as vacuum drying, uni'Is drying, and freeze drying, and converting it into a brown to yellowish brown powder. I can do it.
本発明で゛利用する有効成分を採取するには、上述のよ
うにして得られる液相或は該液相がら液分を除去して得
られた粉末を、前述の如き極性溶媒−水混合系に再溶解
した液相を、更にデル7ρ過法により精製することがで
きる。好ましくは該デル濾過処理によって、分子量約5
(1(11(月ノ、」二の分画を除去して、それ以下
の分画として青汁中の血圧降下成分をより精製された状
態で採取することかできる。IT−ましくは分子量約1
o Ooを超え杓50(1+J I;フ下の分画を採
取することかできるし、分子−滑約10 +i o見、
ドの分画を採取することもできる。In order to collect the active ingredient used in the present invention, the liquid phase obtained as described above or the powder obtained by removing the liquid from the liquid phase is added to the polar solvent-water mixed system as described above. The liquid phase re-dissolved in can be further purified by the del 7ρ filtration method. Preferably, the del filtration process reduces the molecular weight to about 5.
(It is possible to remove the fraction 1 (11 (month), 2) and collect the blood pressure-lowering components in the green juice in a more purified state as the lower fractions. IT- or molecular weight Approximately 1
It is possible to collect the fraction below o Oo, and the fraction below the molecule is about 10 + i o,
It is also possible to collect fractions.
デル?濾過法に用いるが何としては、例えば、合成ゲル
で゛あるデキストランデル、S epl+adcx C
; −25+S(甲11adex G−15,5ep
hadex Ll−120(PI+ar1nacia
Fine Cbe口+1cals社)、F3’+o−
C:clP−6,Blo−Ge1 P−4,8io−
GetP−2等のポリアクリルアミドゲル或は各種アガ
ロースデルの如き枦ヰAをあけることかできる。デル1
濾過操作それ自体は公知の手段で行うことができ、例え
ば゛、既に除へた如く青汁成分中水可溶部の水溶液にエ
ナールアルコールを添加シエチールアルコールノ濃度を
約G(lv/v%になるようにする。析出せる不溶性凝
集物を遠心沈降法で沈降させ、その上清液を分取する。Del? Examples of materials used in the filtration method include dextrandel, which is a synthetic gel, Sepl+adcx C
; -25+S (Kou 11adex G-15, 5ep
hadex Ll-120 (PI+ar1nacia
Fine Cbe mouth + 1 cals), F3'+o-
C: clP-6,Blo-Ge1 P-4,8io-
Polyacrylamide gels such as GetP-2 or gels such as various agarose gels can be opened. Dell 1
The filtration operation itself can be carried out by a known method, for example, by adding enal alcohol to an aqueous solution of the water-soluble portion of the green juice component as already removed, and reducing the concentration of ethyl alcohol to about G (lv/v). %.The insoluble aggregates that can be precipitated are precipitated by centrifugal sedimentation, and the supernatant liquid is collected.
これを減圧下で約115容量になるまで濃縮する。これ
に水を加え溶解せる固形分の濃度を約1%程度になるよ
うに稀釈する。干しめ用意せるセエファテックスG−2
5カラムにカラム容量の約30%量を添加し、水で癩り
溶さす。溶出容量かカラムベット容量の35%に達する
までの流出液を捨て、溶出容量がカラムベット容量の8
0%に達するまでの流出液を採取する。この液にはイネ
科植物の緑葉の青汁の水可溶部成分中の分子量約500
0以下1000前後の成分が9uられる。又上述のカラ
ムベットからの溶出容量を分画的に採取し分子量1oo
o前後のものを選択的に採取することしできる。この目
的のためにセファデックスに−15なとの分別領域の低
いデルを使用することもできる。更に注射薬等にするた
めには更に常用の手段を用いて精製することが゛できる
。This is concentrated under reduced pressure to approximately 115 volumes. Water is added to this to dilute the solution to a concentration of about 1% solids. Cefatex G-2 that can be dried
Add approximately 30% of the column volume to the column and dissolve with water. Discard the eluate until it reaches 35% of the elution volume or column bed volume, and then
Collect the effluent until it reaches 0%. This liquid has a molecular weight of about 500 in the water-soluble component of the green juice of green leaves of grasses.
Components with a value of 0 or less and around 1000 are removed by 9u. In addition, the elution volume from the above-mentioned column bed was collected fractionally and the molecular weight was 1oo.
It is possible to selectively collect those before and after o. It is also possible to use a low del of separation range, such as -15, for Sephadex for this purpose. Furthermore, it can be further purified using conventional means to produce injections and the like.
本発明イネ科植物青汁源血降下剤は、各種の高血圧症に
対して副作用のない優れた薬剤として利用て゛きる。投
与手段としては、例えば、内服、静脈、皮下注射などの
如き投与手段を例示することかて゛きる。The grass-based green juice-based blood-lowering agent of the present invention can be used as an excellent drug without side effects for various types of hypertension. Examples of the administration means include oral administration, intravenous administration, subcutaneous injection, and the like.
本発明血圧降下剤は、各種の剤形で利用することか−(
きる。二のような剤形の例としては、例えは、散剤、類
粒剤、錠剤、液剤等の妬き剤形を例示することか7′き
る。The antihypertensive agent of the present invention can be used in various dosage forms.
Wear. Examples of such dosage forms include powders, granules, tablets, liquids, and the like.
更に、」一連の如き各種の剤形での利用に際して用いる
補助剤の例としては、たとえば、澱粉、砂糖、乳糖、デ
キストリン、水、アルコールの如き、液状らしくは固本
状の稀釈剤もしくは担体類を例示できる。本発明血圧降
下剤の投与量は高血圧症の種類、症状などにより適宜に
選択されるが、例えば、約10〜約51)Omg/kg
体重/日の如き投−5−量を例示することができる。又
、I−D5oは12(’) OOm8/ kg以」二で
殆んど毒性は見られない。Furthermore, examples of adjuvants used for use in various dosage forms include diluents or carriers, whether liquid or solid, such as starch, sugar, lactose, dextrin, water, and alcohol. can be exemplified. The dosage of the antihypertensive agent of the present invention is appropriately selected depending on the type of hypertension, symptoms, etc., and is, for example, about 10 to about 51) Omg/kg.
A dosage such as body weight/day may be exemplified. In addition, I-D5o is 12(')OOm8/kg or more, and almost no toxicity is observed.
以下、有効成分の製造例と共に実施例により、本発明剤
の薬理効果の数例について更に詳しく説明する。Hereinafter, some examples of the pharmacological effects of the agent of the present invention will be explained in more detail using Examples as well as production examples of the active ingredients.
製造例1
大麦若葉(葉茎共)草丈20〜25cmのちの100k
gをよく水洗し、水切り後搾汁機に掛は圧搾磨砕し、次
いで圧縮抽出機で締り粗大固形分(主として繊維)を除
いた緑色を呈した青汁的801をイzまた。これを噴霧
乾燥して約4 、fil kgの緑色の大麦の青汁エキ
ス末を得た。これに本釣401を加え、IL化故に掛は
均一な青汁乳濁液を調整した。これをバスケット型遠心
分^1(機を用い炉布にて微細不溶成分を分離除去し褐
色を呈する青汁成分水可溶部水溶成約3(月を得た。こ
れを約8()〜c、JO°Cに加熱し、熱凝固性不溶化
成分を凝集析出させたのち、これを炉別し、枦成約30
1弱を得た。このものを真空凍結※と燥し、粉末的2
、0 kgを得た。Production example 1 Young barley leaves (both leaves and stems) plant height 20-25cm later 100k
After thoroughly washing with water and draining, the juice is pressed and ground using a squeezer, and then compressed and crushed using a compression extractor to remove coarse solids (mainly fibers), resulting in a green colored green juice 801. This was spray-dried to obtain about 4 fil kg of green barley juice extract powder. Hontsuri 401 was added to this to prepare a homogeneous green juice emulsion due to IL conversion. The fine insoluble components were separated and removed using a basket-type centrifugal centrifugal machine and a furnace cloth to obtain a water-soluble part of the green juice component that turned brown. After heating to JO°C to coagulate and precipitate the heat-coagulable insolubilized components, this was separated into a furnace and was heated to about 30°C.
I got just under 1. This material is vacuum frozen* and dried to form a powder.
, 0 kg was obtained.
これを試料Bとする。This is designated as sample B.
製造例2
製造例1と同様な方法で約301の青汁成分水可溶部水
溶液を得た。この液を攪拌しなから12()1のエチー
ルアルコールを徐々に加える。凝集析出せる約3(lv
/v%エチールアルコールに不溶な成分を遠心分離法に
て分別し上澄成約1101を得た。分離した凝集析出物
区分に80シ/シ%エチールアルコール301を加え攪
拌洗浄し、Fjび遠心分離し」二澄液豹3(月を得た。Production Example 2 An aqueous solution of about 301 water-soluble green juice components was obtained in the same manner as in Production Example 1. While stirring this solution, gradually add ethyl alcohol (12()1). Approximately 3 (lv) that can be coagulated and precipitated
/v% Ethyl alcohol-insoluble components were separated by centrifugation to obtain a supernatant of approximately 110%. 80% ethyl alcohol 301 was added to the separated coagulated precipitate fraction, washed with stirring, and centrifuged to obtain a clear liquid.
これを先の」二(σ液と合し、減圧蒸留しエチールアル
コールの大部分を留去したのち、減圧低温乾燥し粉末的
1゜(几gを得た。これを青汁成分の水可溶性部中80
V / V%エチールアルコール可溶性成分のエキス末
とし、3式料Cとする。This was combined with the previous ``2 (σ liquid), distilled under reduced pressure to remove most of the ethyl alcohol, and then dried under reduced pressure at low temperature to obtain a powder of 1㎜g. Soluble part: 80
V/V% ethyl alcohol-soluble component extract powder, designated as Formula 3 Feeding C.
製造例3
製造例1と同様な方法で得られた青汁成分水可溶部のエ
キス末4kgを水201にとかし濾過する。Production Example 3 4 kg of extract powder of the water-soluble part of the green juice component obtained in the same manner as Production Example 1 was dissolved in water 201 and filtered.
枦成約201を得る。これを径40c+n高さ約10f
−、l cmのガラス製管内にセファデックスG−25
、Coarse型を詰め(ゲルペラ)・容積的661)
たカラムに流す(流速41/m1n)。最初の流出成約
301を除き以降の流出成約531を回収する。このも
のの中には分子量約50 (10以下の低分子物質が含
まれている。これを凍結乾燥して粉末的850gを得た
。これを青汁成分水可溶部のゲル濾過分画低分子画分エ
キス末(試料D)と称する。Obtain 201 points. This diameter is 40c + n height is about 10f
-, Sephadex G-25 in a l cm glass tube.
, Coarse mold packed (gelpera)/volume 661)
(flow rate 41/ml). Excluding the first outflow contract 301, subsequent outflow contracts 531 are collected. This substance contains low molecular weight substances with a molecular weight of approximately 50 (10 or less).This was freeze-dried to obtain 850 g of powder. It is called fraction extract powder (sample D).
比較製造例 1
製造例1と同様に行って得られた大麦若葉の青汁的80
1を、温度90℃で20分間加熱濃縮処理したのち、バ
スケット型遠心分離磯を用い同一液分離操作を行い青汁
成分中の水可溶部を得た。Comparative Production Example 1 Barley grass green juice 80 obtained in the same manner as Production Example 1
1 was heated and concentrated at a temperature of 90° C. for 20 minutes, and then the same liquid separation operation was performed using a basket-type centrifugal rock to obtain the water-soluble portion of the green juice component.
該水可溶部を製造例1と同様にしで真空凍結乾燥して粉
末的1 、8 kg(試料A)を得た。The water-soluble portion was vacuum freeze-dried in the same manner as in Production Example 1 to obtain 1.8 kg of powder (Sample A).
実施例1
薬効試験ニー
〔高血圧自然発生ラッ)(SHR)の血圧に及ぼす影響
〕
10〜12週令の雄のS I−i Rに2・・[時間間
隔で3回、検体を強制経口投与し、投与直後および1.
2.4時間後に(但し3回目の投与の方はその24時間
後にも)水銀マノメーターを介して足動脈圧(収縮期圧
)を非観血的に測定した。用量は、比較例である試料A
群については1500+nε/1(g、製造例1の試料
B群にツいては1500+ng/kb、製造例2の試料
C群については1000 Ing/ kg、製造例3の
試料り群については11000Ioを何れも蒸溜水に溶
解して体重10(1g当りの投与液量か0.5mlにな
るように調整して用い、ほかの蒸溜水のみを同容量投与
するBYを設けて、これを対照)(Yとした。Example 1 Drug efficacy test [Effect on blood pressure of spontaneously hypertensive rats (SHR)] Specimen was forcibly administered orally to 10- to 12-week-old male SI-iRs 2... [3 times at time intervals] Immediately after administration and 1.
2.4 hours later (24 hours after the third administration), foot artery pressure (systolic pressure) was measured non-invasively using a mercury manometer. The dose is that of Sample A, which is a comparative example.
1500 + nε/1 (g) for the sample group B of Production Example 1, 1000 Ing/kg for the sample C group of Production Example 2, and 11000 Io for the sample group of Production Example 3. (Y And so.
使用した動物の数は1群につき6例で、試験開始時にお
ける体重は2 +1 (1〜3 (+ +、I E、血
圧は150〜2 f、l Omu Hgで゛あった。試
験期間中これらの動物はステンレス製飼W籠(中1つ〕
(nl、奥行ンG Cm、高さ20cm)jこ2匹ずつ
収容し、固型飼料(オリエンタルIj¥t!NMド)お
よび水道水を自由に摂取させた。The number of animals used was 6 per group, and the body weight at the start of the study was 2 +1 (1-3 (+ +, IE), blood pressure was 150-2 f, l Omu Hg. During the test period These animals are housed in stainless steel cages (1 medium).
(Nl, Depth G Cm, Height 20 cm) The animals were housed in groups of two and given free access to solid feed (Oriental Ij¥t!NMDO) and tap water.
天験の結果
試料投−り後の血圧の変動を後掲表1お上り添会j図面
に示した。月照群において1土はとんど変動が見られな
かったのに対して各投与群に+5いては血圧の下降かみ
られた。The changes in blood pressure after administering the test results are shown in Table 1 below. In the Moonshine group, almost no change was observed at 1 day, whereas a decrease in blood pressure was observed at 5 days in each administration group.
比較例試料A ] 50 (+ +ngl軸投与群;毎
回投与の1〜2時間後には下降かみられるか其後除々に
上列し、24時間目にはほは′もとのレベルに復した。Comparative Example Sample A] 50 (+ +ngl axis administration group; 1 to 2 hours after each administration, a decline was observed, and then it gradually increased, and by the 24th hour, the level had returned to its original level.
試料81.5 (1(l mg/ k8投与群:毎回投
与の直後に代価を示し、下降11]は比較例試料ノ\よ
り大きく、有意水準]二速する低値を示す。経時的な復
元傾向はあるも全般的1こ回を重ねるに従・、)初回に
比して下νF沖向を示し、比較例△に比へ効果は明らか
に認められる。Sample 81.5 (1 (l mg/k8 administration group: showing the price immediately after each administration, decreasing 11) is greater than the comparative sample, showing a lower value with a significant level]. Restoration over time. Although there is a tendency, as the number of times is repeated, it shows a lower νF offshore than the first time, and the effect on the ratio is clearly recognized in the comparative example △.
試料(: ] (+1を月)+n3/kg、試料1)
100山n3/kH投り群は何jtも顕著な低下を示し
た。脱時的な復元傾向はみしれるか、試料)3よ1)も
更1こ優izだ血圧下降作用を示す。Sample (: ] (+1 for month) + n3/kg, sample 1)
The 100 mountain n3/kHz throwing group showed a significant decrease in several jts. Samples 3 and 1) also show a significantly greater blood pressure lowering effect.
\ ゛\\ ゛\
添刊図面は第1表に示した高血圧自然発生ラットの血圧
に及ぼす本発明血圧降下剤の影響の一例についての血圧
一時間の関係を示すクラ7である。The accompanying drawing is Figure 7 showing the relationship between blood pressure and hour as an example of the effect of the antihypertensive agent of the present invention on the blood pressure of spontaneously hypertensive rats shown in Table 1.
Claims (1)
分中の水可溶部の水溶液から、該水溶液容量に基いて6
0〜80容量%の極性溶媒により形成される不溶性固形
分屋σ/又は該水溶液の70°〜100 ’Cの加熱に
より形成される不溶性固形分を除去した成分を、有効成
分として含有することを特徴とする血圧降下剤。 2、 イネ科植物の緑葉の青汁成分から得られる青汁成
分中の水可溶部の水溶液から、該水溶液容量に基いて6
0〜80容量%の極性溶媒により形成される不溶性固形
分及び/又は該水溶液の7()°〜111 (1”Cの
加熱により形成される不溶性固形分を除去した液相を、
更にゲル濾過処理した成分を、有効成分としで含有する
ことを特徴とする血圧降下剤。[Scope of Claims] 1. From an aqueous solution of the water-soluble portion of the juice component obtained from the green juice component of green leaves of a grass family plant, based on the volume of the aqueous solution, 6.
Contains as an active ingredient an insoluble solid content formed by 0 to 80% by volume of a polar solvent / or a component from which insoluble solid content formed by heating the aqueous solution at 70° to 100'C is removed. Characteristic antihypertensive agent. 2. From an aqueous solution of the water-soluble portion of the green juice component obtained from the green juice component of green leaves of grasses, based on the volume of the aqueous solution, 6.
The insoluble solids formed by 0 to 80% by volume of polar solvent and/or the liquid phase from which the insoluble solids formed by heating the aqueous solution at 7()° to 111 (1"C) are removed,
A hypotensive agent further comprising a gel-filtrated component as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58217830A JPS5939410B2 (en) | 1983-11-21 | 1983-11-21 | Gramineae plant green juice source antihypertensive agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58217830A JPS5939410B2 (en) | 1983-11-21 | 1983-11-21 | Gramineae plant green juice source antihypertensive agent |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53159165A Division JPS5936888B2 (en) | 1978-12-26 | 1978-12-26 | Collection method and agent for blood pressure lowering components in green juice |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59116226A true JPS59116226A (en) | 1984-07-05 |
JPS5939410B2 JPS5939410B2 (en) | 1984-09-22 |
Family
ID=16710412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58217830A Expired JPS5939410B2 (en) | 1983-11-21 | 1983-11-21 | Gramineae plant green juice source antihypertensive agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5939410B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4084916B2 (en) * | 2000-06-21 | 2008-04-30 | 株式会社東洋新薬 | Antihypertensive food containing raw material derived from wheat |
-
1983
- 1983-11-21 JP JP58217830A patent/JPS5939410B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS5939410B2 (en) | 1984-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4948785A (en) | Plant polysaccharide fractions inducing prolactin in mammals | |
WO2013100105A1 (en) | Maillard reaction inhibitor | |
CA1072034A (en) | Method of producing nitrogen-containing polysaccharides | |
US4511559A (en) | Biologically active polysaccharide concentrates and process for production of preparates containing such substances | |
WO2007071334A2 (en) | Ethanol-precipitated phaseolus vulgaris extracts, their use and formulations | |
DK145424B (en) | PROCEDURE FOR MANUFACTURING NITROGEN CONTAINING POLYSACCHARIDES WITH ANTI-TUMOR-EFFECTIVE | |
JPH0539305A (en) | Immuno suppressive polysaccharide extracted from astragalus membranaceous and pharma- ceutical composition containing same | |
US20070148267A1 (en) | Method for producing plant extracts enriched with protease inhibitors for regulation of appetite and food intake in mammals | |
JPS59116226A (en) | Hypotensive agent made from juice of gramineous plant | |
KR102264494B1 (en) | Composition for preventing, improving or treating osteoarthritis using mixture of natural ingredients | |
JP3455436B2 (en) | How to make antioxidants | |
JPS5936888B2 (en) | Collection method and agent for blood pressure lowering components in green juice | |
CN101156930A (en) | A garlic health care capsule for treating cardiac and cerebral vascular diseases and cancer as well as its preparing method | |
KR0124969B1 (en) | Preparation of acidic polysaccharide from white ginseng marc | |
CN115414398B (en) | Chestnut extract, preparation method thereof and application thereof in hypoglycemic products | |
JP3761600B2 (en) | Prolonging herbal extract | |
JP2006028128A (en) | Thrombosis ameliorating agent | |
JPS6372629A (en) | Production of physiologically active extract from ganoderma lucidum karst. | |
JP2001010970A (en) | Antineoplastic fraction from agaricus blazei murill | |
JPS62198399A (en) | Production of physiologically active peptide | |
JP4080296B2 (en) | Antitumor agent | |
JPS6013004B2 (en) | Production method of interferon inducer | |
EP4059509A1 (en) | Agrimonia eupatoria extract preparation method, and composition for improving liver functions or treating liver diseases, containing extract | |
JP3222661B2 (en) | Antitumor agent | |
JPS58172321A (en) | Biologically active protein pr-a obtained from seed of peach and its preparation |